phase readout
saveNCT03927105: Nivolumab and the Antagonistic CSF-1R Monoclonal Antibody Cabiralizumab (BMS-986227) in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma
COMPLETEDupdated 50m ago
community read0 votes
Sponsor: University of Michigan Rogel Cancer Center. Phase: PHASE2. Conditions: Peripheral T Cell Lymphoma
view source ↗
comments(0)
5-min edit window · permanent after that